urinary%20tract%20infection%20in%20women%20-%20complicated
URINARY TRACT INFECTION IN WOMEN - COMPLICATED
Urinary tract infection (UTI) is complicated if the UTI is associated with factors that increases colonization and decreases therapy efficacy. Factors may include one or all of the following: Structural or functional abnormalities of the genitourinary tract; presence of an underlying disease that interferes with host defense mechanisms or the patient being immunocompromised; and being infected by a multi-drug resistant bacteria.
Principles of therapy includes effective antimicrobial antimicrobial therapy, optimal management of the underlying abnormalities or other diseases & adequate life-supporting measures.

History

  • Specific questioning for the presence or absence of prior urinary infections & therapy, genitourinary surgeries, nephrolithiasis, gross hematuria, sickle cell disease & other associated disease predispositions

Laboratory Tests

  • Urine analysis w/ microscopic exam, urine culture & sensitivity testing should be performed before, during & after therapy
  • A pregnancy test may be done in women of reproductive age

Significant Bacteriuria

  • Women: ≥105 colony forming units (cfu)/mL in midstream urine (MSU) sample or >104 cfu/mL in straight catheter urine sample
  • Asymptomatic patients: 2 consecutive urine samples showing ≥105 cfu/mL taken at least 24 hours apart w/ the same bacterial species

Pyuria

  • ≥10 WBC/mm3, though may not be present w/ an obstructed urinary collecting system

Dipstick Method

  • For routine assessment including leukocyte esterase test, hemoglobin & nitrite reaction

Imaging

Further Work-up to Identify & Correct the Anatomical, Functional or Metabolic Abnormality

  • Radiologic studies are indicated to find the cause of complicated urinary tract infection (UTI)
  • Imaging of the urinary tract should be undertaken to evaluate for hydronephrosis, stone disease & urinary tract abnormalities
    • Plain abdominal radiographs may be useful to evaluate for abnormal calcifications, renal contour & gas patterns
    • Intravenous (IV) pyelogram for radiographic images of the bladder, kidneys & ureters to determine extent of urinary obstruction
    • Voiding cystourethrogram for evaluation of the neurogenic bladder & urethral diverticulum, & to determine the presence of vesicoureteral reflux
    • Renal ultrasonography is an extremely valuable tool to evaluate for hydronephrosis, pyonephrosis & perirenal abscesses
    • Computed tomography (CT) scan is more sensitive for nephrolithiasis, defining renal & suprarenal pathology
    • Cystoscopy for a convenient inspection of the urethra & the bladder

Screening

  • Urine specimen for culture should be obtained prior to the administration of antibiotics
    • Selection of antibiotic should be re-evaluated once culture results become available
  • If possible, to avoid the emergence of resistant strains, therapy should be guided by urine culture
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elaine Soliven, 12 Jan 2018
Use of metformin during the first trimester of pregnancy showed no significant maternal or foetal adverse outcomes in women with gestational diabetes mellitus (GDM), according to a study presented at IDF 2017.
Roshini Claire Anthony, 12 Jan 2018

The use of a cervical pessary may reduce the risk of preterm birth in women with singleton pregnancies and short cervical length, according to a single-centre study from Italy.

26 Feb 2017
Placement of cervical pessary in women with short cervices and singleton pregnancies does not lower the risk of having preterm births, according to the results of a meta-analysis.
Roshini Claire Anthony, 07 Sep 2016

Estrogen receptor α (ESR1) mutations Y537S and D538G are associated with reduced overall survival (OS) in patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer, according to findings of a secondary analysis of the BOLERO-2* clinical trial.